Influenza B breakthrough: promising targets for vaccine development
Description
Influenza B viruses are often overlooked but can cause significant illness and mortality, especially in children. Little is known about how the immune system interacts with these viruses, however a recent breakthrough by researchers at the Doherty Institute may revolutionise how we are protected against influenza B and for longer periods.
Tejas Menon, co-author of the recent discovery and PhD Candidate at the Doherty Institute, explains how the immune system consistently recognises fragments of influenza B viruses, which opens up potential new targets for vaccine development.
Show notes:
Peer review: Menon T, Illing P, Chaurasia P, et al. CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age. Nature Communications (2024). DOI: https://doi.org/10.1038/s41467-024-47576-y
Check out our previous episode: Here’s what you need to know about flu season 2024
Get in touch
Have a question or topic you'd like us to explore in a future episode? Contact us via email doherty-media@unimelb.edu.au
See omnystudio.com/listener for privacy information.
United States
